Kai E. Lindevall
Directeur Général chez Encorium Group, Inc.
Profil
Kai E.
Lindevall is the founder of Ipsat Therapies Oy, which was founded in 2000.
Dr. Lindevall is also the founder of Encorium Oy.
Currently, Dr. Lindevall holds the position of President, Chief Executive Officer & Director at Encorium Group, Inc. since 2011.
Additionally, Dr. Lindevall is a Non-Executive Director at Aplagon Oy.
Previously, Dr. Lindevall served as the President & Chief Executive Officer of Remedium Oy.
Dr. Lindevall obtained a doctorate degree from the University of Tampere.
Postes actifs de Kai E. Lindevall
| Sociétés | Poste | Début |
|---|---|---|
Encorium Group, Inc.
 Encorium Group, Inc. Miscellaneous Commercial ServicesCommercial Services Encorium Group, Inc. is a clinical research organization which is engaged in the design and management of complex clinical trials for the pharmaceutical and biotechnology industries. It offers on a global basis broad range of clinical research and development services supporting Phase I through Phase IV clinical trials. The company's services include study protocol design, clinical trials management, global data management services, biostatistics, medical and regulatory affairs, quality assurance and compliance and medical report writing. The Encorium offers therapeutic areas such as vaccines, oncology, CNS/psychiatry, cardiovascular, dermatology, rheumatology, respiratory disorders and renal and urinary disorders. The company was founded on August 1, 1998 and is headquartered in Wayne, Pennsylvania. | Directeur Général | 15/01/2010 |
| Encorium Oy | Directeur Général | 15/01/2010 |
Aplagon Oy
 Aplagon Oy Financial ConglomeratesFinance Aplagon Oy provides pharmaceutical discovery and development services. It develops locally acting antithrombotic products (APACs). The company was founded by Riitta Lassila and Yrjo Sakari Lassila in 2009 and is headquartered in Helsinki, Finland. | Directeur/Membre du Conseil | - |
Anciens postes connus de Kai E. Lindevall
| Sociétés | Poste | Fin |
|---|---|---|
Remedium Oy
 Remedium Oy Miscellaneous Commercial ServicesCommercial Services Remedium Oy is a clinical research organisation providing clinical research services to pharmaceutical, food and biotech companies. Remedium areas of expertise are cardiology and cardiovascular diseases, oncology, immunology and vaccines, CNS, endocrinology and medical devices. The company is headquartered in Espoo, Finland | President | 30/10/2006 |
Ipsat Therapies Oy
 Ipsat Therapies Oy Pharmaceuticals: MajorHealth Technology Ipsat Therapies Oy develops and manufactures antibiotics & drugs. Its products include penicillins, cephalosporins and carbapenems. The firm develops products for the prevention of antibiotic resistance, antibiotic-associated diarrhea and hospital associated infections. The company was founded in 2000 and is headquartered in Helsinki, Finland. | Fondateur | - |
Formation de Kai E. Lindevall
| University of Tampere | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Remedium Oy
Remedium Oy Miscellaneous Commercial ServicesCommercial Services Remedium Oy is a clinical research organisation providing clinical research services to pharmaceutical, food and biotech companies. Remedium areas of expertise are cardiology and cardiovascular diseases, oncology, immunology and vaccines, CNS, endocrinology and medical devices. The company is headquartered in Espoo, Finland | Commercial Services |
Encorium Group, Inc.
Encorium Group, Inc. Miscellaneous Commercial ServicesCommercial Services Encorium Group, Inc. is a clinical research organization which is engaged in the design and management of complex clinical trials for the pharmaceutical and biotechnology industries. It offers on a global basis broad range of clinical research and development services supporting Phase I through Phase IV clinical trials. The company's services include study protocol design, clinical trials management, global data management services, biostatistics, medical and regulatory affairs, quality assurance and compliance and medical report writing. The Encorium offers therapeutic areas such as vaccines, oncology, CNS/psychiatry, cardiovascular, dermatology, rheumatology, respiratory disorders and renal and urinary disorders. The company was founded on August 1, 1998 and is headquartered in Wayne, Pennsylvania. | Commercial Services |
| Encorium Oy | |
Aplagon Oy
Aplagon Oy Financial ConglomeratesFinance Aplagon Oy provides pharmaceutical discovery and development services. It develops locally acting antithrombotic products (APACs). The company was founded by Riitta Lassila and Yrjo Sakari Lassila in 2009 and is headquartered in Helsinki, Finland. | Finance |
Ipsat Therapies Oy
Ipsat Therapies Oy Pharmaceuticals: MajorHealth Technology Ipsat Therapies Oy develops and manufactures antibiotics & drugs. Its products include penicillins, cephalosporins and carbapenems. The firm develops products for the prevention of antibiotic resistance, antibiotic-associated diarrhea and hospital associated infections. The company was founded in 2000 and is headquartered in Helsinki, Finland. | Health Technology |